AAAS: “How the Black Death changed our immune systems” In 2006 a geneticist began studying 318 skeletons, some from deaths from Yersinia pestis, the flea-borne bacterium that causes the plague often called the black death. In the mid–14th century, this pestilence killed 30% to 50% of all people living in Europe, the Middle East, and Africa. Some of the other skeletons were from survivors of the plague who were buried a year or more later in the same medieval cemetery near the Tower of London. Additionally, 198 remains from Denmark were studied. The survivors were much more likely to carry gene variants, one of which increased chances of survival by 40%. This variant became much more common in the human genome after the pandemic was over, + is the “strongest surge of natural selection on the human genome documented so far.” But the trade-off for one of the gene variants is high, in that ‘earlier work has shown it comes with a higher risk of developing autoimmune disorders, such as Crohn’s disease and rheumatoid arthritis.’ Nowadays we have multiple drugs for treatment of Yersinia, including doxycycline, moxifloxacin + chloramphenicol. #epidemiology #genetics

Researchers extracted DNA from the remains of people buried in the East Smithfield plague pits, which were used for mass burials in 1348 and 1349.
Courtesy: Museum of London Archaeology (MOLA)